Select Committee · Health and Social Care Committee

Cancer services

Status: Closed Opened: 6 Jul 2021 Closed: 1 Aug 2022 15 recommendations 15 conclusions 1 report

This inquiry will ask why cancer outcomes in England continue to lag behind comparable countries internationally and examine evidence relating to the underlying causes of these differences. We will also consider what impact disruption to cancer services during the covid-19 pandemic will have on efforts to catch up, and ask whether the ambitions set out … Show more

Clear

Reports

1 report
Title HC No. Published Items Response
Twelfth Report - Cancer services HC 551 5 Apr 2022 30 Responded

Recommendations & Conclusions

1 item
2 Recommendation Twelfth Report - Cancer services Accepted in Part

NHS England has been focusing on encouraging people to come forward with cancer symptoms during...

NHS England has been focusing on encouraging people to come forward with cancer symptoms during the pandemic, which is welcome, and has recently launched a marketing campaign to encourage people to overcome their reluctance to visit their GP to discuss symptoms. However, NHS England should continue to use marketing campaigns … Read more

Government response AI summary
NHS England will extend coverage of non-specific symptom pathways to at least 75% population coverage by March 2023, ensuring at least 65% of urgent cancer referrals meet the Faster Diagnosis Standard and will trial new approaches to prostate cancer and expanding routes into the system …
Read full response →
Department of Health and Social Care

Oral evidence sessions

5 sessions
Date Witnesses
20 Jan 2022 Dame Cally Palmer · NHS England, Judith Neptial, cancer patient, Maria Caulfield · Department of Health and Social Care, Mark Foulkes · Royal Berkshire NHS Foundation Trust, Professor Peter Johnson · NHS England, William Vineall · Department of Health and Social Care View ↗
9 Nov 2021 Anna Jewell · Less Survivable Cancers Taskforce, Ian Vousden · Kent and Medway Cancer Alliance, Jane Lyons · Cancer52, Katy Hall, Expert by experience, Professor David Baldwin · School of Medicine (University of Nottingham), Professor David Shackley · Greater Manchester Cancer, Sarah Stevens · National Disease Registration Service, NHS Digital View ↗
26 Oct 2021 Baroness Delyth Morgan · Breast Cancer Now, David Watson · The Association of the British Pharmaceutical Industry (ABPI), Dr Philippa Hetherington, Expert by experience, Professor David Cunningham · Association of Cancer Physicians, Professor Mike Griffin · Royal College of Surgeons of Edinburgh, Professor Nick James · Institute of Cancer Research, Professor Pat Price · Action Radiotherapy View ↗
14 Sep 2021 Andrea Brady, person with lived experience, Dr Andrew Millar · North Central London Cancer Alliance, Dr Jeanette Dickson · Council of the Academy of Medical Royal Colleges, Dr Richard Roope · Royal College of General Practitioners, Michelle Mitchell · Cancer Research UK, Professor Peter Sasieni · King's College London, Clinical Trials Unit, Sir Harpal Kumar · GRAIL Europe View ↗
13 Jul 2021 Dame Cally Palmer · NHS England, John Butler · International Cancer Benchmarking Partnership, Prof Jon Emery · University of Melbourne, Prof Peter Johnson · NHS England, Prof Sir Mike Richards, Former National Cancer Director View ↗

Who gave evidence

31 witnesses
WitnessOrganisationSessions
Dame Cally Palmer · National Cancer Director NHS England 2
Andrea Brady, person with lived experience 1
Anna Jewell · Chair Less Survivable Cancers Taskforce 1
Baroness Delyth Morgan · Chief Executive Breast Cancer Now 1
David Watson · Executive Director of Economic, Health and Commer… The Association of the British Pharmaceutical Industry (ABPI) 1
Dr Andrew Millar · Rapid Diagnostic Centre Lead North Central London Cancer Alliance 1
Dr Jeanette Dickson · Chair Council of the Academy of Medical Royal Colleges 1
Dr Philippa Hetherington, Expert by experience 1
Dr Richard Roope · Clinical Adviser for Cancer Royal College of General Practitioners 1
Ian Vousden · Programme Director Kent and Medway Cancer Alliance 1
Jane Lyons · Chief Executive Officer Cancer52 1
John Butler · Clinical Lead International Cancer Benchmarking Partnership 1
Judith Neptial, cancer patient 1
Katy Hall, Expert by experience 1
Maria Caulfield · Parliamentary Under-Secretary of State Department of Health and Social Care 1
Mark Foulkes · Macmillan Lead Cancer Nurse Royal Berkshire NHS Foundation Trust 1
Michelle Mitchell · Chief Executive Officer Cancer Research UK 1
Prof Jon Emery · Chair of Primary Care Cancer Research University of Melbourne 1
Prof Peter Johnson · National Clinical Director for Cancer NHS England 1
Prof Sir Mike Richards, Former National Cancer Director 1
Professor David Baldwin · Consultant Respiratory Physician and Honorary Pro… School of Medicine (University of Nottingham) 1
Professor David Cunningham · Chair Association of Cancer Physicians 1
Professor David Shackley · Director Greater Manchester Cancer 1
Professor Mike Griffin · President Royal College of Surgeons of Edinburgh 1
Professor Nick James · Prostate and Bladder Cancer Team Leader Institute of Cancer Research 1
Professor Pat Price · Consultant Clinical Oncologist and Chair Action Radiotherapy 1
Professor Peter Johnson · National Clinical Director for Cancer NHS England 1
Professor Peter Sasieni · Academic Director King's College London, Clinical Trials Unit 1
Sarah Stevens · Deputy Director National Disease Registration Service, NHS Digital 1
Sir Harpal Kumar · President GRAIL Europe 1
William Vineall · Director of NHS Quality, Safety and Investigations Department of Health and Social Care 1

Correspondence

3 letters
DateDirectionTitle
29 Mar 2022 Corresondence from the National Cancer Director on the Cancer services inquiry
25 Jan 2022 To cttee Letter from the National Cancer Director and National Clinical Director on Canc…
19 Oct 2021 To cttee Letter from Jeanette Dickson providing further information requested by the Com…